| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032916A2 Organosulfur inhibitors of tyrosine phosphatases |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030078427 Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078274 Method of reducing neuronal injury or apoptosis |
| 04/24/2003 | US20030078256 Serotonin receptor antagonist; treating cardiovascular disorder |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | CA2464412A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2cactivity |
| 04/24/2003 | CA2463724A1 Organosulfur inhibitors of tyrosine phosphatases |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/23/2003 | EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 04/23/2003 | EP1303502A2 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 04/23/2003 | EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 04/23/2003 | EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/22/2003 | US6552052 Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | CA2239187C Inhibitors of farnesyl protein transferase |
| 04/17/2003 | US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents |
| 04/17/2003 | US20030073047 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent |
| 04/16/2003 | EP1302462A1 Sulfone derivatives, process for their production and use thereof |
| 04/16/2003 | EP1301493A2 Heterocycle carboxamides as antiviral agents |
| 04/16/2003 | EP0922045B1 Bicyclic pyrimidine derivatives and their use as anti-coagulants |
| 04/16/2003 | CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 04/15/2003 | US6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/10/2003 | WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | WO2003028734A1 Triazepine derivatives as neurotrophic agents |
| 04/10/2003 | WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/10/2003 | WO2003028725A1 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands |
| 04/10/2003 | WO2003028641A2 Mch receptor antagonists |
| 04/10/2003 | WO2003006470A3 THIAZOLO [4,5-b]PYRIDINES AS FUNGICIDES |
| 04/10/2003 | WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders |
| 04/10/2003 | US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects |
| 04/10/2003 | US20030069268 Applying to animals, plants, environment |
| 04/10/2003 | US20030069219 Core modified porphyrins |
| 04/10/2003 | CA2462643A1 Triazepine derivatives as neurotrophic agents |
| 04/10/2003 | CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | CA2460594A1 Mch receptor antagonists |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP0902684B1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
| 04/08/2003 | USRE38073 Biosynthesis; using dehydration agent |
| 04/08/2003 | US6545033 GABA receptor inhibitors |
| 04/08/2003 | US6544997 E.g., hypermotility, irritable bowel syndrome, bowel hypersensitivity and the reduction of pain associated with gastrointestinal hypersensitivity and/or hyperactivity |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | CA2112165C Bicyclic amine derivatives |
| 04/03/2003 | WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | US20030065180 Anticancer agents; kidney disease |
| 04/03/2003 | US20030065179 Diabetic therapy |
| 04/03/2003 | US20030065031 Glucagon antagonists/inverse agonists |
| 04/03/2003 | US20030065006 Viricides; anticancer agents |
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/03/2003 | US20030064968 Viricides, anticarcinogneic agents |
| 04/03/2003 | US20030064954 Gene therapy; vaccines; calcium channel blockers; cardiovascular disorders |
| 04/03/2003 | CA2461363A1 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | CA2461360A1 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/02/2003 | WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds |
| 04/02/2003 | EP1296985A2 Heteropolycyclic inhibitors |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296942A1 Glucagon antagonists/inverse agonists |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/01/2003 | US6541618 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6540820 Polymer soluble color agent for coloring toners, powders and powder coating materials as well as for coloring ink-jet inks; heat stability and light fastness |
| 03/27/2003 | WO2003024941A1 Naphthalene compounds and use thereof as drugs |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 03/27/2003 | WO2002014321A9 Use of stat-6 inhibitors as therapeutic agents |
| 03/27/2003 | US20030060624 Reacting 2-chloro-4- trifluoromethyl-phenyl)-acetonitrile in the presence of a palladium catalyst and a base to form indene derivative |
| 03/27/2003 | US20030060482 Urease inhibitors |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/26/2003 | EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 03/26/2003 | CN1406227A Aryl fused azapolycy clic compounds |
| 03/26/2003 | CN1406182A Benzbisazole compound and optical recording medium containing the compound |
| 03/26/2003 | CN1103769C Tricyclic amine derivatives |
| 03/20/2003 | US20030055266 Small molecule modulators of G protein-coupled receptors |
| 03/20/2003 | US20030055250 Pteridine compounds for the treatment of psoriasis |
| 03/20/2003 | US20030055094 Bicyclic modulators of androgen receptor function |
| 03/20/2003 | US20030055068 Pyrazole compounds useful as protein kinase inhibitors |
| 03/20/2003 | US20030055050 CRF receptor antagonists and methods relating thereto |
| 03/20/2003 | US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient |
| 03/20/2003 | US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions |
| 03/20/2003 | US20030055031 As anticonvulsants; for therapy and prophylaxis of ischaemias, anoxia, neurodegenerative diseases |
| 03/19/2003 | EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 03/19/2003 | EP1149106B1 4,5-azolo-oxindoles |
| 03/19/2003 | CN1404482A Pteridine compounds for the treatment of psoriasis |
| 03/18/2003 | US6534520 Antiviral compounds |